Upgrade to SI Premium - Free Trial

Capricor Therapeutics (CAPR)

8.10 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/26)

Latest Headlines

Oppenheimer Reiterates Outperform Rating on Capricor Therapeutics (CAPR) October 8, 2026 4:50 AM - StreetInsider Caprock Provides 2026 Operational Highlights and an Update on its 2027 Work Program at Destiny October 7, 2026 7:33 AM - StreetInsider Capricor's DMD drug slows upper limb decline in 24-month study October 5, 2026 9:02 AM - StreetInsider Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress October 5, 2026 9:00 AM - Globe NewsWire Oppenheimer Reiterates Outperform Rating on Capricor Therapeutics (CAPR) Ahead of Presentaion September 17, 2026 10:28 AM - StreetInsider Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress September 17, 2026 8:30 AM - Globe NewsWire Form SCHEDULE 13G CAPRICOR THERAPEUTICS, Filed by: MILLENNIUM MANAGEMENT LLC September 14, 2026 6:54 PM - SEC Filing B.Riley Upgrades Capricor Therapeutics (CAPR) to Buy September 14, 2026 3:48 AM - StreetInsider Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline September 2, 2026 9:39 PM - StreetInsider Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26' September 1, 2026 9:07 AM - StreetInsider Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight 'Ahead of Extended 11/22 PDUFA Date' September 1, 2026 3:47 AM - StreetInsider Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 31, 2026 1:11 PM - StreetInsider Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 28, 2026 5:49 PM - StreetInsider Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 26, 2026 9:39 PM - StreetInsider Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism' August 25, 2026 6:57 AM - StreetInsider Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 24, 2026 12:18 PM - StreetInsider Increasing unusual put volume: CAPR EYPT WPM ROST CBRG LNC FVRR IOT IOVA PR BNTX TEVA HWM MRNA BLSH BMNU August 24, 2026 10:54 AM - StreetInsider FDA extends Capricor deramiocel review to November 22, HC Wainwright comments August 24, 2026 10:20 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: Aug 24 August 24, 2026 9:25 AM - SEC Filing FDA extends Capricor's deramiocel review deadline to November 2026 August 24, 2026 9:25 AM - StreetInsider Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA August 24, 2026 9:25 AM - Globe NewsWire Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 21, 2026 4:56 PM - StreetInsider Kaos Capital pushes for board changes at Capricor Therapeutics August 21, 2026 7:47 AM - StreetInsider Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders August 21, 2026 7:45 AM - PR NewsWire Form SCHEDULE 13G CAPRICOR THERAPEUTICS, Filed by: MILLENNIUM MANAGEMENT LLC August 19, 2026 7:07 PM - SEC Filing Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 19, 2026 4:33 PM - StreetInsider Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 17, 2026 11:55 AM - StreetInsider Increasing unusual put option volume: IHI CAPR BW CPRT FIGR BKR VIK MXEF AMPG CRGY PAGP August 17, 2026 5:22 AM - StreetInsider Form 10-Q CAPRICOR THERAPEUTICS, For: Jun 30 August 14, 2026 4:46 PM - SEC Filing Form SCHEDULE 13G/A CAPRICOR THERAPEUTICS, Filed by: TANG CAPITAL MANAGEMENT LLC August 14, 2026 4:22 PM - SEC Filing Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 14, 2026 3:44 PM - StreetInsider These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started August 14, 2026 1:14 PM - StreetInsider Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight August 14, 2026 2:50 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: Aug 13 August 13, 2026 4:10 PM - SEC Filing Capricor Therapeutics (CAPR) Misses Q2 EPS by 10c August 13, 2026 4:07 PM - StreetInsider Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update August 13, 2026 4:06 PM - Globe NewsWire Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 13, 2026 3:43 PM - StreetInsider CAPR INVESTOR ALERT: Capricor Therapeutics Securities Class Action Filed; September 28, 2026 Lead Plaintiff Deadline - Kehoe Law Firm August 11, 2026 12:19 PM - StreetInsider Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 10, 2026 1:45 PM - StreetInsider Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13 August 10, 2026 8:30 AM - Globe NewsWire Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 7, 2026 2:44 PM - StreetInsider Form SCHEDULE 13G CAPRICOR THERAPEUTICS, Filed by: STATE STREET CORP August 7, 2026 8:56 AM - SEC Filing Form SCHEDULE 13G CAPRICOR THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P. August 3, 2026 4:37 PM - SEC Filing Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline August 3, 2026 3:05 PM - StreetInsider CAPR INVESTIGATION: Block & Leviton Seeks to Speak With Capricor Therapeutics Investors July 31, 2026 9:01 AM - StreetInsider Capricor Therapeutics (CAPR) PT Lowered to $5 at B.Riley July 31, 2026 8:15 AM - StreetInsider Jones Trading Downgrades Capricor Therapeutics (CAPR) to Hold July 30, 2026 4:32 PM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: Jul 29 July 30, 2026 4:05 PM - SEC Filing Increasing unusual put volume: CAPR SFM EXE TEVA WMB IRM TRV BXSL INSM AAP CI RSP KORU ALT CHKP FITB TDOC WOLF July 30, 2026 10:39 AM - StreetInsider FDA panel votes against Capricor's Deramiocel for DMD heart disease July 30, 2026 9:30 AM - StreetInsider Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel July 30, 2026 9:30 AM - Globe NewsWire Maxim Group Downgrades Capricor Therapeutics (CAPR) to Hold July 30, 2026 8:42 AM - StreetInsider Oppenheimer Downgrades Capricor Therapeutics (CAPR) to Perform July 30, 2026 7:54 AM - StreetInsider Ladenburg Thalmann Downgrades Capricor Therapeutics (CAPR) to Neutral July 30, 2026 7:32 AM - StreetInsider H.C. Wainwright Downgrades Capricor Therapeutics (CAPR) to Neutral July 30, 2026 5:58 AM - StreetInsider Piper Sandler Downgrades Capricor Therapeutics (CAPR) to Neutral July 30, 2026 2:52 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: Jul 29 July 29, 2026 10:05 AM - SEC Filing The Lancet publishes Capricor's phase 3 DMD therapy trial results July 29, 2026 10:05 AM - StreetInsider The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy July 29, 2026 10:05 AM - Globe NewsWire CAPR INVESTIGATION: Capricor Therapeutics Investors Should Contact Block & Leviton About Recovering Their Losses July 29, 2026 7:46 AM - StreetInsider Increasing unusual call option volume: AVTR CAPR GLNG KORU MUU BCS JCI NRG July 29, 2026 3:54 AM - StreetInsider Alliance Global Partners Downgrades Capricor Therapeutics (CAPR) to Neutral July 28, 2026 7:04 AM - StreetInsider Increasing unusual put option volume: CAPR XLC CG METC CHYM AIQ BKR July 28, 2026 6:22 AM - StreetInsider Roth/MKM Downgrades Capricor Therapeutics (CAPR) to Neutral July 27, 2026 3:47 PM - StreetInsider Jones Trading on Capricor Therapeutics (CAPR): 'this is the first time we have seen the magnitude of difference in primary outcome' July 27, 2026 2:36 PM - StreetInsider H.C. Wainwright on Capricor Therapeutics (CAPR): 'Cage Match Expected at Wednesday's AdCom as Drama with FDA Continues' July 27, 2026 12:31 PM - StreetInsider B.Riley Downgrades Capricor Therapeutics (CAPR) to Neutral July 27, 2026 11:02 AM - StreetInsider Capricor disputes FDA briefing materials ahead of deramiocel review July 27, 2026 11:00 AM - StreetInsider Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel July 27, 2026 11:00 AM - Globe NewsWire Increasing unusual put option volume: CAPR BETA UCO CRH BKR METC OTLK CIA TCOM EQNR July 27, 2026 10:48 AM - StreetInsider Oppenheimer Reiterates Capricor Therapeutics (CAPR) at Outperform, 'like the risk-reward' July 27, 2026 10:12 AM - StreetInsider Capricor Therapeutics (CAPR) Falls 26% Following FDA Briefing Docs Post July 27, 2026 7:55 AM - StreetInsider Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald July 15, 2026 7:48 AM - StreetInsider Form 8-K CAPRICOR THERAPEUTICS, For: Jul 09 July 14, 2026 5:06 PM - SEC Filing Full Article List